Provided by Tiger Fintech (Singapore) Pte. Ltd.

ENDRA Life Sciences Inc

4.10
+0.24326.31%
Post-market: 4.100.00000.00%19:52 EDT
Volume:10.74K
Turnover:42.20K
Market Cap:2.20M
PE:-0.03
High:4.10
Open:3.85
Low:3.64
Close:3.86
Loading ...

What Makes ENDRA Life Sciences (NDRA) a New Strong Buy Stock

Zacks
·
29 Jan

ENDRA Life Sciences Inc trading resumes

TIPRANKS
·
30 Nov 2024

ENDRA Life Sciences Inc trading halted, volatility trading pause

TIPRANKS
·
30 Nov 2024

BRIEF-Endra Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

Reuters
·
22 Nov 2024

Endra Life Sciences regains compliance with Nasdaq

TIPRANKS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
22 Nov 2024

ENDRA Life Sciences Regains Compliance with Nasdaq Minimum Bid Price Requirement

Business Wire
·
22 Nov 2024

ENDRA Life Sciences Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
15 Nov 2024

ENDRA Life Sciences Q3 EPS $(9.54)

Benzinga
·
15 Nov 2024

ENDRA Life Sciences Inc: Qtrly Loss per Share $9.54

THOMSON REUTERS
·
15 Nov 2024

ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

THOMSON REUTERS
·
15 Nov 2024

Press Release: ENDRA Life Sciences Reports Third Quarter 2024 Financial Results and Provides a Business Update

Dow Jones
·
15 Nov 2024

Study Highlighting ENDRA Life Sciences’ TAEUS Technology in Patients with High BMI to be Presented at AASLD’s The Liver Meeting® 2024

Business Wire
·
12 Nov 2024

ENDRA Life Sciences Inc expected to post a loss of $62.30 a share - Earnings Preview

Reuters
·
08 Nov 2024

ENDRA Life Sciences Inc trading halted, news pending

TIPRANKS
·
07 Nov 2024

ENDRA Life Sciences Further Strengthens TAEUS® Platform Intellectual Property with Issuance of 17th European Patent

Business Wire
·
06 Nov 2024